Hint mode is switched on Switch off

XBI - SPDR S&P Biotech ETF (USD) (US78464A8707)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Choose all Reset all
 
(%)
US78464A8707
XBI ISIN
Exchange Traded Funds (ETF)
Type of fund
SPDR State Street Global Advisors
Provider
158.32 USD
NAV per Share | 29/06/2026
31/01/2006
Inception Date
4 times per year
Dividend payments
CEOILS
CFI
XBI
Ticker
Formed
Status
Equity
Investment category
Biotech
Sector
USA
Investor locations
S&P Biotechnology Select Industry Index
Benchmark
0.35 %
Total Cost Ratio
10,939.57 mln USD
Fund NAV | 29/06/2026
10,939.57 mln USD
Share Class NAV | 29/06/2026
No
UCITS
1 / 3 (11/09/2015)
Split

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Yield on 29/06/2026, NYSE Arca

  • YTD
    5.06 %
  • 1M
    -7.93 %
  • 3M
    1.65 %
  • 6M
    11.2 %
  • 1Y
    62.15 %
  • 3Y
    51.47 %
  • 5Y
    0.91 %
  • 10Y
    143.19 %
At the price on the exchange, taking into account income payments

Latest data on
Add to compare
from
to
ADD-IN
Cbonds add-in API
bond data api

Quotes (XBI)

Explore the most comprehensive database

1 000 000

bonds

80 234

stocks

167 970

ETF & Funds

70 000

indices

Track your portfolio in the most efficient way

  • Bond Search
  • Watchlist
  • Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 900 000 bonds, 80 000 stocks, 116 000 ETF & Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Price dynamics

Fund profile

The SPDR S&P Biotech ETF seeks to replicate as closely as possible the price and yield performance of the S&P Biotechnology Select Industry Index by investing in a portfolio comprised primarily of U.S. companies in the biotechnology sector

XBI profile

The SPDR S&P Biotech ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The SPDR State Street Global Advisors fund’s base currency is USD and the share class was registered 31.01.2006 with unique ISIN - US78464A8707. Main exchange is NYSE Arca and ticker symbol is XBI. The total expense ratio is 0.35%. The SPDR S&P Biotech ETF (USD) pays dividends 4 time(s) per year.

Structure XBI on 26/06/2026

Download structure in Excel
Paper Value
APOGEE THERAPEUTICS INC 1.49%
MODERNA INC 1.4%
PRAXIS PRECISION MEDICINES I 1.35%
TWIST BIOSCIENCE CORP 1.35%
ORUKA THERAPEUTICS INC 1.34%
VIKING THERAPEUTICS INC 1.32%
KYMERA THERAPEUTICS INC 1.3%
ERASCA INC 1.27%
SELLAS LIFE SCIENCES GROUP I 1.24%
CG ONCOLOGY INC 1.24%
REVOLUTION MEDICINES INC 1.24%
MIRUM PHARMACEUTICALS INC 1.21%
CYTOKINETICS INC 1.21%
RHYTHM PHARMACEUTICALS INC 1.19%
VAXCYTE INC 1.18%
NATERA INC 1.17%
DIANTHUS THERAPEUTICS INC 1.16%
RELAY THERAPEUTICS INC 1.16%
TRAVERE THERAPEUTICS INC 1.16%
SCHOLAR ROCK HOLDING CORP 1.16%
COGENT BIOSCIENCES INC 1.14%
ROIVANT SCIENCES LTD 1.13%
KRYSTAL BIOTECH INC 1.12%
SPYRE THERAPEUTICS INC 1.11%
ALKERMES PLC 1.11%
TG THERAPEUTICS INC 1.11%
BEAM THERAPEUTICS INC 1.1%
CELCUITY INC 1.08%
PROTAGONIST THERAPEUTICS INC 1.07%
VERA THERAPEUTICS INC 1.06%
VERTEX PHARMACEUTICALS INC 1.06%
UNIQURE NV 1.06%
INSMED INC 1.06%
CRISPR THERAPEUTICS AG 1.06%
ARROWHEAD PHARMACEUTICALS IN 1.05%
ABBVIE INC 1.05%
ULTRAGENYX PHARMACEUTICAL IN 1.05%
MADRIGAL PHARMACEUTICALS INC 1.04%
BIOGEN INC 1.03%
PTC THERAPEUTICS INC 1.03%
IMMUNITYBIO INC 1.02%
IONIS PHARMACEUTICALS INC 1.02%
HALOZYME THERAPEUTICS INC 1.01%
INCYTE CORP 1.01%
SUMMIT THERAPEUTICS INC 0.99%
BRIDGEBIO PHARMA INC 0.99%
AMGEN INC 0.99%
NEUROCRINE BIOSCIENCES INC 0.98%
REGENERON PHARMACEUTICALS 0.97%
GILEAD SCIENCES INC 0.96%
EXELIXIS INC 0.96%
BIOMARIN PHARMACEUTICAL INC 0.95%
ALNYLAM PHARMACEUTICALS INC 0.93%
ACADIA PHARMACEUTICALS INC 0.93%
UNITED THERAPEUTICS CORP 0.93%
NUVALENT INC A 0.93%
IMMUNOVANT INC 0.92%
GRAIL INC 0.91%
INTELLIA THERAPEUTICS INC 0.89%
TANGO THERAPEUTICS INC 0.88%
CATALYST PHARMACEUTICALS INC 0.87%
BIOCRYST PHARMACEUTICALS INC 0.85%
VERACYTE INC 0.84%
DENALI THERAPEUTICS INC 0.84%
DYNE THERAPEUTICS INC 0.82%
IDEAYA BIOSCIENCES INC 0.79%
RECURSION PHARMACEUTICALS A 0.76%
ARCUS BIOSCIENCES INC 0.75%
ARCUTIS BIOTHERAPEUTICS INC 0.73%
SYNDAX PHARMACEUTICALS INC 0.72%
AGIOS PHARMACEUTICALS INC 0.71%
SAREPTA THERAPEUTICS INC 0.71%
CELLDEX THERAPEUTICS INC 0.71%
MINERALYS THERAPEUTICS INC 0.71%
VIRIDIAN THERAPEUTICS INC 0.69%
DISC MEDICINE INC 0.66%
NOVAVAX INC 0.66%
ADMA BIOLOGICS INC 0.61%
PALVELLA THERAPEUTICS INC 0.59%
IMMUNOME INC 0.59%
IOVANCE BIOTHERAPEUTICS INC 0.57%
ABSCI CORP 0.55%
NURIX THERAPEUTICS INC 0.55%
BIOHAVEN LTD 0.53%
KODIAK SCIENCES INC 0.53%
VERICEL CORP 0.5%
HYPERLIQUID STRATEGIES 0.5%
ANAPTYSBIO INC 0.48%
CAPRICOR THERAPEUTICS INC 0.48%
VIR BIOTECHNOLOGY INC 0.48%
STOKE THERAPEUTICS INC 0.47%
MONTE ROSA THERAPEUTICS INC 0.47%
TYRA BIOSCIENCES INC 0.42%
CULLINAN THERAPEUTICS INC 0.41%
CORVUS PHARMACEUTICALS INC 0.4%
PRECIGEN INC 0.39%
AVALO THERAPEUTICS INC 0.36%
ARDELYX INC 0.36%
INHIBRX BIOSCIENCES INC 0.36%
TAYSHA GENE THERAPIES INC 0.35%
Show more Hide
Other - %

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Other ETF & Funds from this provider

Similar ETF & Funds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} mln
    NAV
    {{ item.expense_ratio }}
    Total Cost Ratio
Registration is required to get access.